Clinical Trial Update: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Diclofenac Sodium Gel 3% to Solaraze 3% in actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac Sodium Gel 3% (diclofenac sodium gel 3%)
• Solaraze Gel 3% (Diclofenac Sodium) (Diclofenac)

Snippet

Sponsor: Actavis Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2020-07-20